Extraovarian endometrioid carcinoma associated with unopposed oestrogen replacement therapy

S Sidhu, Sidhu S, Sandeep Singh Sidhu, Edwards L, L Edwards, Lindsay A. Edwards, Rainer Stange, Rainer S, S Rainer, O'Connor T, Terence W. O'Connor, T O'connor
The Australian & New Zealand journal of obstetrics & gynaecology · 1998 · vol. 38(1) , pp. 125–127 · doi:10.1111/j.1479-828x.1998.tb02981.x · PMID:9521415 · W2024089699
Case report OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

This case report describes a woman with endometriosis who developed extraovarian endometrioid carcinoma after prolonged unopposed estrogen therapy following hysterectomy and bilateral oophorectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

EDITORIAL COMMENT: We accepted this case report for publication because, apart from being interesting, it raises the question of the appropriate hormone replacement therapy after bilateral oophorectomy (usually with hysterectomy) has been performed when there is evidence of endometriosis. Menopausal symptoms in these women can be relieved by oestrogen therapy without return of pelvic pain or dyspareunia. The authors report a case of endometrial‐like carcinoma in a woman with known endometriosis after a hysterectomy and prolonged unopposed oestrogen therapy. Although this is a solitary case report, the authors explain that there are 8 others in the literature where malignancy occurred in extraovarian endometriosis after bilateral oophorectomy associated with unopposed oestrogen. One of our reviewers commented that a combination of oestrogen and progestogen should always be considered when prescribing hormone replacement therapy in women with a known history of endometriosis, following total hysterectomy and bilateral oophorectomy.

My notes (saved in your browser only)

Condition tags

endometriosisdyspareunia

MeSH descriptors

Carcinoma, Endometrioid Estrogen Replacement Therapy Estrogens, Conjugated (USP) Pelvic Neoplasms Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Contraindications Contraindications Endometriosis Endometriosis Endometriosis Endometriosis Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Female Female Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (11)

Cited by (2)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:35.617750+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK